New Drug Approvals Archive
Get news by email or subscribe to our news feeds.
March 2003
| March 13 |
Fuzeon (enfuvirtide)Date of Approval: March 13, 2003 Fuzeon (enfuvirtide) is a fusion inhibitor used in combination with other medicines to treat HIV infection. |
| March 20 |
Femring (estradiol acetate) Vaginal RingDate of Approval: March 20, 2003 Femring (estradiol acetate) is a vaginal estrogen product in the form of a flexible, self-inserted ring. Femring is indicated to treat both the hot flushes and vaginal symptoms associated with menopause. |
| March 25 |
Somavert (pegvisomant) for InjectionDate of Approval: March 25, 2003 Somavert (pegvisomant) is a growth hormone receptor antagonist indicated for the treatment of acromegaly. |
| March 27 |
Emend (aprepitant) CapsulesDate of Approval: March 27, 2003 Emend (aprepitant) is a P/neurokinin 1 (NK1) receptor antagonist used in combination with other antiemetic agents to prevent and control acute and delayed nausea and vomiting associated with chemotherapy. |
